Scrip
US FDA approves Pfizer's intravenous Revatio
23 November 2009
Asher Mullard
Please Login to read the full article.
23 November 2009
Asher Mullard
The US FDA has approved an intravenous formulation of Pfizer's Revatio (sildenafil; also known as Viagra) for the treatment of pulmonary arterial hypertension (PAH). With this approval, Revatio becomes the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet...
Please Login to read the full article.
RELATED CONTENT
FEATURES
- Anti-obesity drugs: an inventor's perspective
- Face-to-face: The FDA, Amgen, and its blockbuster biologic, denosumab
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
